BREEDLOVE ROBERT CHARLES (Principal Accounting Officer) sold 1.0% of their position (461.00 shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $5.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2025ACC: 0000950170-25-113822
Officer· Principal Accounting Officer
Since Feb 2026
-461.00
Net shares
Net seller
$5.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
461.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−461.00
Price / share
$12.09
Trade value
$5.57K
% of position
1.0%
9/5/2025
48.39K→47.93K
Total
Net shares
−461.00
Net value
-$5.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2025 | S · Sale | −461.00 | $12.09 | $5.57K | 1.0% | 48.39K | 47.93K |
| Total | −461.00 | -$5.57K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.95K
Total
6.95K indirect6.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.95K | Indirect |
| Total | 6.95K | 6.95K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported